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Abstract 
 
Background: Klebsiella oxytoca is a Gram-negative member of the human microbiota but can cause urinary 
infection and other infections. It can be detected in the intestines of about 2 to 10% of healthy subjects, and until 
recently, K. oxytoca was considered to be a commensal member of the enteric microflora. However, it has been 
shown that K. oxytoca is in fact an intestinal pathobiont and the causative agent of antibiotic-associated hemorrhagic 
colitis (AAHC). The aim of this work was, therefore, to isolate Klebsiella strains from all possible source of 
infection, and to modify and set up a simple technique to detect the serum resistance in these isolates and biofilm 
formation in these strains by test tube method. We also want to see antibiogram of K. oxytoca isolates since this may 
guide pre-emptive therapy. Objectivesis the isolation and identification of K. oxytoca from different samples and 
performing serum resistance and biofilm assessment by test tube method in these strains as well as observing 
resistance to common antibiotics in these bacteria. Material and methods of the study sample consisted of one 
hundred (100) clinical isolates of K. oxytoca. Gram staining and standard biochemical tests used for clinical 
diagnosis, among the isolates. A total of 100 isolates of Klebsiella oxytoca, from various samples (stool, urine, pus, 
sputum, blood). Out of these, 58 infected patients were male and 42 patients were female. 
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Introduction 
Klebsiella oxytoca is a Gram-negative member of the 
human microbiota but can cause urinary infection and 
other infections[1]. It can be detected in the intestines 
of about 2 to 10% of healthy subjects, and until 
recently, K. oxytoca was considered to be a commensal 
member of the enteric microflora [1, 2]. However, it 
has been shown that K. oxytoca is in fact an intestinal 
pathobiont and the causative agent of antibiotic-
associated hemorrhagic colitis (AAHC) [2]. It is very 
important to know which infections are caused by this 
pathogen and what is the usual pattern of antibiotic 
resistance in this pathogen in order to guide the 
clinician in antibiotic therapy. 
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Virulence factors of this pathogen are also important to 
know.K. oxytoca is implicated in not only urinary 
infection but also antibiotic associated colitis [3]. 
Under conditions of intestinal dysbiosis, a state of 
microbial imbalance, K. oxytoca unleashes its 
pathogenic potential. Several factors can perturb the 
intestinal microbiota during the life span of an 
individual, including immune deficiency, infections, 
dietary changes, and drugs, like antibiotics [4, 5]. The 
consequences of antibiotic-induced intestinal dysbiosis 
range from diarrheal symptoms to intestinal 
inflammation and infection. The characteristics of 
AAHC are sudden onset of bloody diarrhea and 
abdominal cramps during penicillin or cephalosporin 
therapy. The antibiotic penicillin is considered critical 
for triggering dysbiosis, as K. oxytoca exhibits a 
natural resistance to penicillins[5]. Rapid colonic 
overgrowth of K. oxytoca follows during the acute 
phases of AAHC [3]. The pathogenicity of K. 
oxytoca in colitis is not understood, but a correlation 
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has been observed between isolates originating from 
AAHC patients and the secretion of cytotoxin(s) [1, 2, 
6]. Besides the potential to induce colitis under certain 
circumstances, enteric carriage of K. oxytoca may be 
important for the transmission of antibiotic resistance 
genes to other bacteria and as a source of nosocomial 
infections [7, 8]. Indeed, this bacterium and the closely 
related species Klebsiellapneumoniae are important 
human pathogens causing hepatobiliary infections and 
infections of the urinary tract and soft tissue, in 
addition to nosocomial pneumonia [9-11]. In recent 
years, multidrug-resistant strains of both species have 
emerged as an important problem in the health care 
system [7, 12]. So far, no typing method has 
successfully identified a clonal relationship between K. 
oxytoca isolates with respect to the particular infections 
they cause, their isolation source, or their toxicity [6, 
13]. One property that has been suggested to be 
important in the ability of bacteria to cause infection is 
resistance to the bactericidal effect of human serum. In 
the present study, Klebsiella strains from different 
sources will be examined for sensitivity to human 
serum. Bacteria belonging to the genus Klebsiella 
frequently cause human infections, gastrointestinal 
tract being the main reservoir of Klebsiella[14]. The 
most common area of bacterial colonization of this 
pathogen is the urinary tract: in the community setting 
is reported to cause from 2 to 15% of cystitis cases 
[15]. Also, the incidence of Klebsiella pneumoniae 
increases in the hospital infections [14]. While 
different typing methods are useful epidemiological 
tools for infection control, recent findings about 
Klebsiella virulence factors have provided new insights 
into the pathogenic strategies of these bacteria [15]. 
Klebsiellaproduces fimbriae that mediate attachment to 
host mucosal surface, a capsule that protect against 
phagocytosis and other immune responses, and similar 
to all Gram negative organisms immunosuppressive 
lipopolysaccharide (LPS) [14]. Biofilms are complex 
communities of microorganisms attached to a surface 
or interface enclosed in an exopolysaccharide matrix of 
microbial and host origin to produce a spatially 
organized three dimensional structure [18, 19]. 
Biofilms are universal, occurring in aquatic and 
industrial water systems as well as a large number of 
environments and medical devices relevant for public 
health. Using sophisticated analytical tools, biofilm 
researchers now understand that biofilms are not 
unstructured, homogeneous deposits of cells and 
accumulated slime, but complex communities of 
surface-associated cells enclosed in a polymer matrix 
containing open water channels. Microorganisms 
growing in a biofilm are highly resistant to 
antimicrobial agents by one or more mechanisms. 
Biofilm-associated microorganisms have been shown 
to be associated with several human diseases, and to 
colonize a wide variety of medical devices [17]. The 
role of biofilm formation and development by bacteria 
has been suggested to be an important stage in the 
pathogenesis of Klebsiella[20, 21]. When the formation 
of biofilm is conceived in the urinary tract, always the 
catheter related infections (CAI), one of the first 
recognized and most studied biofilm diseases, must be 
included. It is clear that biofilms are associated with 
urinary tract infection (UTI) where indwelling device 
are not the cause: bacteria show to form biofilm on 
bladder mucosal tissue and on the mucosal surface of 
the acini of prostate tissue in a rat model of bacterial 
prostatitis [16]. The formation of biofilms within the 
urinary tract is one of the best explanation for the 
recurrent and chronic infections [16]. The urinary tract 
is protected from pathogen colonization by the flushing 
action of sterile urine, the sloughing of uroepithelial 
cells and a glycosaminoglycan layer. The resulting 
limitations on the therapeutic options demand new 
measures for the management of the infections 
produced by the responsible pathogens. Then, research 
on alternatives therapies are increasing, that include 
probiotic products at different tracts or mucosa. More 
specifically, in the lower urinary tract, organisms as 
Lactobacillus species prevent pathogens from attaching 
and establishing a tissue infection [22]. The aim of this 
work was, therefore, to isolate Klebsiella strains from 
all possible source of infection, and to modify and set 
up a simple technique to detect the serum resistance in 
these isolates and biofilm formation in these strains by 
test tube method. We also want to see antibiogram of 
K. oxytoca isolates since this may guide pre-emptive 
therapy. 
Material and methods  
The proposed study is a Descriptive (lab-based 
observational) study was carried out in the Department 
of Microbiology, All India Institute of Medical 
Sciences, Patna, from November 2016 to October 
2017. The study sample consisted of one hundred (100) 
clinical isolates of K. oxytoca. Gram staining from the 
mucoid lactose fermenting colonies and standard 
biochemical tests used for clinical diagnosis, among 
the isolates, K. oxytoca were identified on the basis of 
their colony morphology, characteristics in Triple sugar 
iron, Christensen’s urea agar and Simmons citrate 
media and differentiated from K. pneumoniae by indole 
positivity. Which were inoculated on Cysteine lactose 
electrolyte deficient agar (for urine) and Sheep blood 
agar and MacConkey agar (other samples) and 
incubated overnight at 370C. After isolation and 
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identification of K. oxytoca from different samples. We 
perform serum resistance and biofilm assessment by 
test tube method in these strains and observing 
resistance to common antibiotics in these bacteria. 
Antibiogram: Isolates will be inoculated on Mueller 
Hinton agar by Lawn culture and antibiotic 
susceptibility following standard guidelines (CLSI) 
(Kirby Bauer method)[23]. The following antibiotics 
will be tested: Ampicillin (10 mcg.), Amoxyclav (30 
mcg.), Cotri-moxazole (25 mcg.), Levofloxacin (5 
mcg.) and Azithromycin(15 mcg).Serum resistance 
testing technique: Isolates will be suspended in 200µl 
Peptone water up to 1 MacFarlane suspension. This 
was divided into two halves. To one half 300 µl fresh 
human serum was added and to the other half 300 µl 
peptone water was added.  The two tubes were 
incubated for 90 minutes at 370C and then from each 
tube subcultures were made on either half of a nutrient 
agar plate and incubated overnight at 370C. Growth 
obtained were compared next day and upto 99% 
reduction in growth obtained from serum is considered 
as susceptible to serum. Biofilm formation: Growth 
from culture plates were inoculated in 5ml peptone 
broth and after overnight incubation at 37°C, next day 
washout with normal saline one times then add 0.5% 
safranin for 1 minute, then wash with normal saline 
twice after drying the test tube we observe for biofilm 
formation.Statistical methods are not needed in this 
study since it is descriptive only. 
Results   
From November 2016 to October 2017, a total of 100 
isolates of Klebsiella oxytoca, from various samples 
(stool, urine, pus, sputum, blood). Out of these, 58 
infected patients were male and 42 patients were 
female. From these 100 samples, serum resistance was 
seen in 55 isolates, biofilm formation in 35 isolates. 
Both serum resistance and biofilm formation was 
present in 30 isolates. With respect to antibiogram, 
ampicillin was the most resistant (80 isolates) drug, 
followed by amoxyclav (71 isolates) and cotrimoxazole 
(36 isolates). Most sensitive among all the antibiotics 
used was azithromycin (74 isolates) followed by 
levofloxacin (69 isolates).There is no any side effect. 
Hopefully some new insights will come up regarding 
pathogenesis and antibiogram which will help in 
instituting empirical therapy in infections produced by 
K. oxytoca. 
 
Fig. 1: Test for biofilm forming ability 
Discussion 
These findings will be important and literature is scarce 
in this topic, so this study will be interesting to see and 
carry out. Serum resistance in isolates, especially 
urinary isolates will help clinicians to know that the 
particular serum-resistant urinary isolate has propensity 
to cause septicemia on gaining access to bloodstream 
from urinary tract. Biofilm forming isolates will 
indicate that therapy needs to be tailored accordingly. 
 
 
Conclusion  
This study demonstrates the presence of important 
virulence mechanisms viz. biofilm forming ability, 
serum resistance in a high proportion of Klebsiella 
oxytoca isolates which may be responsible for its 
persistence in the environment as well as in the human 
body. Demonstration of resistance to multiple drugs 
tested indicates the emergence of multi-drug resistant 
Klebsiella oxytoca isolates in our clinical setting 
raising a concern of difficulty in treating infections 
caused by the mentioned organism. 
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